ライフサイエンスコーパス: rhinosinusitis

1 eased incidences of sinonasal infections and rhinosinusitis.

2 iseases, such as cystic fibrosis and chronic rhinosinusitis.

3 onization, fungus balls, and allergic fungal rhinosinusitis.

4 seases ranging from colonization to invasive rhinosinusitis.

5 fungal sinusitis, and acute fulminant fungal rhinosinusitis.

6 review the diagnosis and treatment of acute rhinosinusitis.

7 r of spontaneously resolving acute bacterial rhinosinusitis.

8 sinusitis who present for treatment of acute rhinosinusitis.

9 reating patients with upper airway bacterial rhinosinusitis.

10 ntly been associated with asthma and chronic rhinosinusitis.

11 in particular those of patients with chronic rhinosinusitis.

12 was a risk factor for noninfectious rhinitis/rhinosinusitis.

13 can arbitrarily be divided into rhinitis and rhinosinusitis.

14 characteristics very similar to eosinophilic rhinosinusitis.

15 the relationship between work exposures and rhinosinusitis.

16 Among patients with acute rhinosinusitis, a 10-day course of amoxicillin compared

17 In patients with chronic rhinosinusitis, a novel endotyping approach purely based

18 e report herein two cases of allergic fungal rhinosinusitis accompanied by bone destruction of the ad

19 Final diagnosis was allergic fungal rhinosinusitis (AFRS) in both cases.

20 ts with CRS had a higher prevalence of acute rhinosinusitis, allergic rhinitis, chronic rhinitis, ast

21 ays, such as otitis media, adenotonsillitis, rhinosinusitis and adenoid hypertrophy.

22 or the clinical diagnosis of acute bacterial rhinosinusitis and for those with severe rhinosinusitis

23 nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role in type

24 nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role in type

25 All of the patients had chronic rhinosinusitis and nasal polyposis, and these responses

26 n accordance with the European guidelines on rhinosinusitis and nasal polyps (EPOS 2012), CT is used

27 RS defined by the European Position Paper on Rhinosinusitis and Nasal Polyps.

28 exact role of microbial biofilms in chronic rhinosinusitis and orbital cellulitis were not elucidate

29 ability of the clinical isolates in chronic rhinosinusitis and orbital cellulitis, and to look for t

30 ential of these organisms in causing chronic rhinosinusitis and orbital cellulitis.

31 fections, chronic invasive and granulomatous rhinosinusitis, and aspergillus bronchitis.

32 adult-onset asthma, nasal polyposis, chronic rhinosinusitis, and aspirin sensitivity.

33 ronic obstructive pulmonary disease, chronic rhinosinusitis, and asthma.

34 act diseases including otitis media, chronic rhinosinusitis, and exacerbations of both cystic fibrosi

35 tissue homogenates in patients with chronic rhinosinusitis, and this effect was most prominent in CR

36 espiratory tract infection," "pharyngitis," "rhinosinusitis," and "the common cold." HIGH-VALUE CARE

37 opriate antibiotic use for adults with acute rhinosinusitis apply to the diagnosis and treatment of a

38 Bacterial and viral rhinosinusitis are difficult to differentiate on clinica

39 features mimic essential aspects of chronic rhinosinusitis-associated olfactory loss, and illuminate

40 To explore the mechanisms underlying rhinosinusitis-associated olfactory loss, we have genera

41 Airway diseases such as chronic rhinosinusitis, asthma, and chronic obstructive pulmonar

42 usitis recommend that the diagnosis of acute rhinosinusitis be based on the presence of "cardinal sym

43 RD) is a risk factor for developing rhinitis/rhinosinusitis, but data are lacking.

44 ad prevalence of allergic, viral and chronic rhinosinusitis, but how the brain encodes and maintains

45 Acute viral rhinosinusitis can be difficult to distinguish from acut

46 l reflux disease, postnasal drip syndrome or rhinosinusitis, chronic obstructive pulmonary disease, p

47 specimens derived from patients with chronic rhinosinusitis compared to control patients.

48 Allergic rhinitis (AR), chronic rhinosinusitis (CRS) and asthma often co-exist.

49 ic sinonasal inflammation, including chronic rhinosinusitis (CRS) and cystic fibrosis.

50 and immune pathways associated with chronic rhinosinusitis (CRS) are not fully understood.

51 nisms of activation in patients with chronic rhinosinusitis (CRS) are not known.

52 iotic therapy is often initiated for chronic rhinosinusitis (CRS) based on symptomatology.

53 Asthma and chronic rhinosinusitis (CRS) both impair quality of life, but th

54 It is increasingly recognized that chronic rhinosinusitis (CRS) comprises a spectrum of different d

55 ovide composite criteria to evaluate chronic rhinosinusitis (CRS) control, taking into consideration

56 Chronic rhinosinusitis (CRS) defines a group of disorders charac

57 Chronic rhinosinusitis (CRS) has a broad range of comorbidities.

58 Chronic rhinosinusitis (CRS) has been known as a disease with st

59 Chronic rhinosinusitis (CRS) has been linked to the gram-positiv

60 in and its function in patients with chronic rhinosinusitis (CRS) have not been fully explored.

61 e of asthma and its association with chronic rhinosinusitis (CRS) have not been widely studied in pop

62 Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regard

63 criteria to study the prevalence of chronic rhinosinusitis (CRS) in a general-population sample.

64 robial interactions in patients with chronic rhinosinusitis (CRS) in hopes of elucidating mechanisms

65 Chronic rhinosinusitis (CRS) is a common condition in the US gen

66 Chronic rhinosinusitis (CRS) is a common disease with still uncl

67 Chronic rhinosinusitis (CRS) is a complex disease consisting of

68 Chronic rhinosinusitis (CRS) is a disease characterized by infla

69 Chronic rhinosinusitis (CRS) is a frequent condition that is tre

70 Chronic rhinosinusitis (CRS) is a heterogeneous disease characte

71 Chronic rhinosinusitis (CRS) is a multifactorial disease of the

72 Chronic rhinosinusitis (CRS) is a prevalent condition with under

73 Chronic rhinosinusitis (CRS) is a prevalent multifactorial disea

74 Chronic rhinosinusitis (CRS) is a troublesome, chronic inflammat

75 Chronic rhinosinusitis (CRS) is an inflammation of the nose and

76 Chronic rhinosinusitis (CRS) is an inflammatory disease of the u

77 Chronic rhinosinusitis (CRS) is an inflammatory disease that aff

78 Chronic rhinosinusitis (CRS) is an inflammatory process in the n

79 Patients with chronic rhinosinusitis (CRS) often have comorbid asthma.

80 of the underlying cause or causes of chronic rhinosinusitis (CRS) over the past 20 or more years have

81 ently, ILC2s enrichment was noted in chronic rhinosinusitis (CRS) patients; however, the role of ILC2

82 The cause of chronic rhinosinusitis (CRS) remains unclear.

83 Although chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) is chara

84 s, were collected from patients with chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) or witho

85 Chronic rhinosinusitis (CRS) without nasal polyps (CRSsNP) and C

86 osinophilia, which is in contrast to chronic rhinosinusitis (CRS) without nasal polyps (NPs).

87 ronchodilator lung function, asthma, chronic rhinosinusitis (CRS), and atopy with age using a large E

88 mucosal diseases, including asthma, chronic rhinosinusitis (CRS), and eosinophilic esophagitis.

89 nasal polyps (NPs) of patients with chronic rhinosinusitis (CRS), as well as in bronchoalveolar lava

90 the high prevalence and morbidity of chronic rhinosinusitis (CRS), little is known about the mechanis

91 tems, we identified respondents with chronic rhinosinusitis (CRS), migraine headache, and fatigue sym

92 ed outcomes during the management of chronic rhinosinusitis (CRS), PROMs will play an essential role

93 ithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS), respectively.

94 fibrinolytic system in patients with chronic rhinosinusitis (CRS).

95 coagulation factors in patients with chronic rhinosinusitis (CRS).

96 t roles in inflammatory processes in chronic rhinosinusitis (CRS).

97 ithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS).

98 obulin deficiencies in patients with chronic rhinosinusitis (CRS).

99 sample with subjects with asthma and chronic rhinosinusitis (CRS).

100 plays a role in the exacerbation of chronic rhinosinusitis (CRS); however, the mechanism for this is

101 -to-treat CRS was defined as noncontrollable rhinosinusitis despite successful sinus surgery and appr

102 Most cases of acute rhinosinusitis diagnosed in ambulatory care are caused b

103 study to use the European Position Paper on Rhinosinusitis (EPOS) criteria to study the prevalence o

104 ifficult to distinguish from acute bacterial rhinosinusitis, especially during the first 10 days of s

105 s with CRS, which was defined as symptomatic rhinosinusitis for more than 12 weeks and documented imm

106 hould reserve antibiotic treatment for acute rhinosinusitis for patients with persistent symptoms for

107 rs may impact upon airway disease, including rhinosinusitis, gastroesophageal reflux disease, obesity

108 morbidities are discussed: rhinitis, chronic rhinosinusitis, gastroesophageal reflux, obstructive sle

109 Invasive disease includes indolent chronic rhinosinusitis, granulomatous fungal sinusitis, and acut

110 Chronic rhinosinusitis has a significant impact on patient quali

111 onship between allergic rhinitis and chronic rhinosinusitis has been assessed in a number of observat

112 We found that patients with chronic rhinosinusitis have elevated glucose concentrations in t

113 tial management of suspected acute bacterial rhinosinusitis in adults and children were prepared by a

114 and treatment of acute maxillary and ethmoid rhinosinusitis in adults who are not immunocompromised.

115 Complications of acute bacterial rhinosinusitis in children are rare.

116 orticosteroids are beneficial to treat acute rhinosinusitis in patients with a history of chronic or

117 hould reserve antibiotic treatment for acute rhinosinusitis in patients with persistent symptoms for

118 robiota: Staphylococcus aureus infection and rhinosinusitis in the nasal-sinus mucosa, as well as cys

119 e bacteria commonly associated with clinical rhinosinusitis in vitro.

120 r 10 days, the likelihood of acute bacterial rhinosinusitis increases, and initiation of antibiotic t

121 smitted infections, cystic fibrosis, chronic rhinosinusitis, inflammatory bowel disease, and glaucoma

122 Acute rhinosinusitis is a common ailment accounting for millio

123 Chronic rhinosinusitis is a consistent feature of the autosomal

124 The pathogenesis of chronic rhinosinusitis is a growing area of interest, but there

125 Acute bacterial rhinosinusitis is an infection of the nasal epithelium a

126 ce to support antibiotic treatment for acute rhinosinusitis is limited, yet antibiotics are commonly

127 e included acute inflammation (n=6), chronic rhinosinusitis (n=2), and allergic rhinitis (n=20) and u

128 Patients develop chronic eosinophilic rhinosinusitis, nasal polyposis, and asthma.

129 Recurrent CRS was defined as rhinosinusitis not controlled by appropriate conservativ

130 onize the respiratory tract and cause fungal rhinosinusitis or bronchopulmonary aspergillosis.

131 etions in pathologic states, such as chronic rhinosinusitis or hyperglycemia, promotes tonic activati

132 e cases, given the likelihood of acute viral rhinosinusitis or of spontaneously resolving acute bacte

133 ing disease (asthma, nasal polyps or chronic rhinosinusitis, or both), as well as on the methodology

134 es (Short-Form Health Questionnaire, 31-item Rhinosinusitis Outcome Measuring Instrument, and Asthma

135 onic obstructive pulmonary disease, acquired rhinosinusitis, pancreatitis, and lethal secretory diarr

136 Chronic rhinosinusitis patients with 1 CF mutation were evaluate

137 s flavus which is a common cause of allergic rhinosinusitis, postoperative aspergillosis and fungal k

138 gh rarely some patients with acute bacterial rhinosinusitis present with dramatic symptoms of severe

139 s and treatment of acute viral and bacterial rhinosinusitis recommend that the diagnosis of acute rhi

140 Acute rhinosinusitis resolves without antibiotic treatment in

141 The clinical diagnosis of acute bacterial rhinosinusitis should be reserved for patients with rhin

142 mptoms of asthma, allergic rhinitis, chronic rhinosinusitis, smoking status, and history of NSAID-ind

143 ed from malignant disease or invasive fungal rhinosinusitis, so an understanding of the clinical feat

144 AIDs was higher in participants with chronic rhinosinusitis symptoms (Odds Ratio 2.12; 95%CI 1.78-2.7

145 nusitis should be reserved for patients with rhinosinusitis symptoms lasting 7 days or more who have

146 Patients with rhinosinusitis symptoms that last less than 7 days are u

147 ial rhinosinusitis and for those with severe rhinosinusitis symptoms-especially those with unilateral

148 of neural and mucosal dysregulation in each rhinosinusitis syndrome.

149 Among patients with nasal polyps and chronic rhinosinusitis, the prevalence was 9.69% (95% CI, 2.16%

150 rflow is also a contributing factor in human rhinosinusitis, this in vivo model demonstrates for the

151 edius range in severity from bite wounds and rhinosinusitis to endocarditis; historically, these infe

152 mechanism in patients with aspirin-sensitive rhinosinusitis to the bronchial mucosa in patients with

153 pecimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitative PCR,

154 ) patients with clinical features of chronic rhinosinusitis were examined; patients with first-onset

155 ed trial of adults with uncomplicated, acute rhinosinusitis were recruited from 10 community practice

156 Chronic rhinosinusitis with nasal polyposis (CRSwNP) in Western

157 role for mast cells is suggested in chronic rhinosinusitis with nasal polyposis (CRSwNP), which is c

158 ncinate tissue (UT) of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and those with

159 A number of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) are resistant

160 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex i

161 Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated

162 Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated

163 Although chronic rhinosinusitis with nasal polyps (CRSwNP) is characteriz

164 1 and its ligands PD-L1 and PD-L2 in chronic rhinosinusitis with nasal polyps (CRSwNP) is poorly stud

165 is without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) using real-wor

166 sitis without nasal polyps (CRSsNP), chronic rhinosinusitis with nasal polyps (CRSwNP), and aspirin-e

167 icoid receptor (GR) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

168 Chronic rhinosinusitis with nasal polyps (NP) and allergic rhini

169 irway inflammatory diseases, such as chronic rhinosinusitis with nasal polyps and asthma, show increa

170 piratory disease is a severe form of chronic rhinosinusitis with nasal polyps in which nearly all pat

171 Chronic rhinosinusitis with nasal polyps is associated with loca

172 Chronic rhinosinusitis with nasal polyps is characterized by TH2

173 ost from infections in patients with chronic rhinosinusitis with nasal polyps.

174 of premorbid medical conditions for chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic

175 9, at lower extent, in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) in comparis

176 LFs) from controls and patients with chronic rhinosinusitis without nasal polyps (CRSsNP), chronic rh

177 nasal polyps (CRSwNP) and those with chronic rhinosinusitis without nasal polyps (CRSsNP; P < .01).

178 from control subjects, patients with chronic rhinosinusitis without nasal polyps, and patients with c